| UniProt ID | NDC1_HUMAN | |
|---|---|---|
| UniProt AC | Q9BTX1 | |
| Protein Name | Nucleoporin NDC1 | |
| Gene Name | NDC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 674 | |
| Subcellular Localization |
Nucleus, nuclear pore complex. Nucleus membrane Multi-pass membrane protein. Central core structure of the nuclear pore complex. |
|
| Protein Description | Component of the nuclear pore complex (NPC), which plays a key role in de novo assembly and insertion of NPC in the nuclear envelope. Required for NPC and nuclear envelope assembly, possibly by forming a link between the nuclear envelope membrane and soluble nucleoporins, thereby anchoring the NPC in the membrane.. | |
| Protein Sequence | MATAVSRPCAGRSRDILWRVLGWRIVASIVWSVLFLPICTTVFIIFSRIDLFHPIQWLSDSFSDLYSSYVIFYFLLLSVVIIIISIFNVEFYAVVPSIPCSRLALIGKIIHPQQLMHSFIHAAMGMVMAWCAAVITQGQYSFLVVPCTGTNSFGSPAAQTCLNEYHLFFLLTGAFMGYSYSLLYFVNNMNYLPFPIIQQYKFLRFRRSLLLLVKHSCVESLFLVRNFCILYYFLGYIPKAWISTAMNLHIDEQVHRPLDTVSGLLNLSLLYHVWLCGVFLLTTWYVSWILFKIYATEAHVFPVQPPFAEGSDECLPKVLNSNPPPIIKYLALQDLMLLSQYSPSRRQEVFSLSQPGGHPHNWTAISRECLNLLNGMTQKLILYQEAAATNGRVSSSYPVEPKKLNSPEETAFQTPKSSQMPRPSVPPLVKTSLFSSKLSTPDVVSPFGTPFGSSVMNRMAGIFDVNTCYGSPQSPQLIRRGPRLWTSASDQQMTEFSNPSPSTSISAEGKTMRQPSVIYSWIQNKREQIKNFLSKRVLIMYFFSKHPEASIQAVFSDAQMHIWALEGLSHLVAASFTEDRFGVVQTTLPAILNTLLTLQEAVDKYFKLPHASSKPPRISGSLVDTSYKTLRFAFRASLKTAIYRITTTFGEHLNAVQASAEHQKRLQQFLEFKE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 339 | Ubiquitination | LQDLMLLSQYSPSRR HHHHHHHHCCCHHHH | 24.10 | 21963094 | |
| 342 | Phosphorylation | LMLLSQYSPSRRQEV HHHHHCCCHHHHHEE | 14.57 | 28348404 | |
| 344 | Phosphorylation | LLSQYSPSRRQEVFS HHHCCCHHHHHEEEE | 33.87 | - | |
| 362 | Ubiquitination | PGGHPHNWTAISREC CCCCCCCHHHHHHHH | 5.56 | 33845483 | |
| 363 | Ubiquitination | GGHPHNWTAISRECL CCCCCCHHHHHHHHH | 21.30 | 21963094 | |
| 366 | Phosphorylation | PHNWTAISRECLNLL CCCHHHHHHHHHHHH | 21.40 | 32645325 | |
| 376 | Ubiquitination | CLNLLNGMTQKLILY HHHHHCCHHHHHHHH | 3.31 | 33845483 | |
| 378 | Ubiquitination | NLLNGMTQKLILYQE HHHCCHHHHHHHHHH | 29.66 | 21963094 | |
| 379 | Ubiquitination | LLNGMTQKLILYQEA HHCCHHHHHHHHHHH | 28.47 | 21963094 | |
| 390 | Ubiquitination | YQEAAATNGRVSSSY HHHHHHHCCCCCCCC | 31.39 | 23000965 | |
| 394 | Phosphorylation | AATNGRVSSSYPVEP HHHCCCCCCCCCCCC | 16.53 | 19691289 | |
| 395 | Phosphorylation | ATNGRVSSSYPVEPK HHCCCCCCCCCCCCC | 30.91 | 19691289 | |
| 396 | Phosphorylation | TNGRVSSSYPVEPKK HCCCCCCCCCCCCCC | 26.42 | 19691289 | |
| 397 | Phosphorylation | NGRVSSSYPVEPKKL CCCCCCCCCCCCCCC | 17.16 | 28152594 | |
| 397 | Ubiquitination | NGRVSSSYPVEPKKL CCCCCCCCCCCCCCC | 17.16 | 21963094 | |
| 401 | Ubiquitination | SSSYPVEPKKLNSPE CCCCCCCCCCCCCCH | 39.04 | 22817900 | |
| 402 (in isoform 2) | Ubiquitination | - | 57.28 | 21890473 | |
| 402 | Ubiquitination | SSYPVEPKKLNSPEE CCCCCCCCCCCCCHH | 57.28 | 21963094 | |
| 403 (in isoform 1) | Ubiquitination | - | 64.71 | 21890473 | |
| 403 (in isoform 4) | Ubiquitination | - | 64.71 | 21890473 | |
| 403 | Ubiquitination | SYPVEPKKLNSPEET CCCCCCCCCCCCHHH | 64.71 | 21906983 | |
| 406 | Phosphorylation | VEPKKLNSPEETAFQ CCCCCCCCCHHHCCC | 44.09 | 19664994 | |
| 410 | Phosphorylation | KLNSPEETAFQTPKS CCCCCHHHCCCCCCH | 30.98 | 30266825 | |
| 414 | Phosphorylation | PEETAFQTPKSSQMP CHHHCCCCCCHHCCC | 26.65 | 29255136 | |
| 415 | Ubiquitination | EETAFQTPKSSQMPR HHHCCCCCCHHCCCC | 24.61 | 27667366 | |
| 416 | Ubiquitination | ETAFQTPKSSQMPRP HHCCCCCCHHCCCCC | 67.15 | 33845483 | |
| 417 | Phosphorylation | TAFQTPKSSQMPRPS HCCCCCCHHCCCCCC | 27.32 | 25159151 | |
| 418 | Phosphorylation | AFQTPKSSQMPRPSV CCCCCCHHCCCCCCC | 36.30 | 25159151 | |
| 424 | Phosphorylation | SSQMPRPSVPPLVKT HHCCCCCCCCCCCCH | 48.84 | 25159151 | |
| 429 | Ubiquitination | RPSVPPLVKTSLFSS CCCCCCCCCHHHHCC | 8.62 | 21890473 | |
| 429 (in isoform 2) | Ubiquitination | - | 8.62 | 21890473 | |
| 429 | Ubiquitination | RPSVPPLVKTSLFSS CCCCCCCCCHHHHCC | 8.62 | 21890473 | |
| 430 (in isoform 1) | Ubiquitination | - | 39.83 | 21890473 | |
| 430 (in isoform 4) | Ubiquitination | - | 39.83 | 21890473 | |
| 430 | Ubiquitination | PSVPPLVKTSLFSSK CCCCCCCCHHHHCCC | 39.83 | 23000965 | |
| 431 | Phosphorylation | SVPPLVKTSLFSSKL CCCCCCCHHHHCCCC | 24.15 | 28122231 | |
| 432 | Phosphorylation | VPPLVKTSLFSSKLS CCCCCCHHHHCCCCC | 23.00 | 21815630 | |
| 435 | Phosphorylation | LVKTSLFSSKLSTPD CCCHHHHCCCCCCCC | 31.68 | 21815630 | |
| 436 (in isoform 2) | Ubiquitination | - | 30.22 | 21890473 | |
| 436 | Phosphorylation | VKTSLFSSKLSTPDV CCHHHHCCCCCCCCC | 30.22 | 17192257 | |
| 436 | Ubiquitination | VKTSLFSSKLSTPDV CCHHHHCCCCCCCCC | 30.22 | 21963094 | |
| 436 | Ubiquitination | VKTSLFSSKLSTPDV CCHHHHCCCCCCCCC | 30.22 | 21890473 | |
| 437 (in isoform 1) | Ubiquitination | - | 45.30 | 21890473 | |
| 437 | Ubiquitination | KTSLFSSKLSTPDVV CHHHHCCCCCCCCCC | 45.30 | 21963094 | |
| 437 (in isoform 4) | Ubiquitination | - | 45.30 | 21890473 | |
| 439 | Phosphorylation | SLFSSKLSTPDVVSP HHHCCCCCCCCCCCC | 41.45 | 22617229 | |
| 440 | Phosphorylation | LFSSKLSTPDVVSPF HHCCCCCCCCCCCCC | 33.66 | 26055452 | |
| 445 | Phosphorylation | LSTPDVVSPFGTPFG CCCCCCCCCCCCCCC | 17.85 | 26055452 | |
| 449 | Phosphorylation | DVVSPFGTPFGSSVM CCCCCCCCCCCHHHH | 18.80 | 26055452 | |
| 453 | Phosphorylation | PFGTPFGSSVMNRMA CCCCCCCHHHHHHHC | 21.82 | 25850435 | |
| 454 | Phosphorylation | FGTPFGSSVMNRMAG CCCCCCHHHHHHHCC | 26.26 | 25850435 | |
| 467 | Phosphorylation | AGIFDVNTCYGSPQS CCCCCCCCCCCCCCC | 13.62 | 23663014 | |
| 469 | Phosphorylation | IFDVNTCYGSPQSPQ CCCCCCCCCCCCCHH | 20.71 | 29255136 | |
| 470 | Ubiquitination | FDVNTCYGSPQSPQL CCCCCCCCCCCCHHH | 34.69 | 21963094 | |
| 471 | Phosphorylation | DVNTCYGSPQSPQLI CCCCCCCCCCCHHHH | 8.03 | 29255136 | |
| 474 | Phosphorylation | TCYGSPQSPQLIRRG CCCCCCCCHHHHHCC | 20.28 | 29255136 | |
| 486 | Phosphorylation | RRGPRLWTSASDQQM HCCCCCEECCCHHCC | 21.00 | 22199227 | |
| 487 | Phosphorylation | RGPRLWTSASDQQMT CCCCCEECCCHHCCC | 17.75 | 22199227 | |
| 489 | Phosphorylation | PRLWTSASDQQMTEF CCCEECCCHHCCCCC | 35.40 | 22199227 | |
| 490 | Ubiquitination | RLWTSASDQQMTEFS CCEECCCHHCCCCCC | 42.31 | 29967540 | |
| 494 | Phosphorylation | SASDQQMTEFSNPSP CCCHHCCCCCCCCCC | 29.55 | 22199227 | |
| 495 | Ubiquitination | ASDQQMTEFSNPSPS CCHHCCCCCCCCCCC | 41.56 | 24816145 | |
| 497 | Phosphorylation | DQQMTEFSNPSPSTS HHCCCCCCCCCCCCC | 41.41 | 25159151 | |
| 500 | Phosphorylation | MTEFSNPSPSTSISA CCCCCCCCCCCCCCC | 35.42 | 25159151 | |
| 502 | Phosphorylation | EFSNPSPSTSISAEG CCCCCCCCCCCCCCC | 38.84 | 30278072 | |
| 503 | Phosphorylation | FSNPSPSTSISAEGK CCCCCCCCCCCCCCC | 33.20 | 30278072 | |
| 504 | Phosphorylation | SNPSPSTSISAEGKT CCCCCCCCCCCCCCC | 20.91 | 25159151 | |
| 506 | Phosphorylation | PSPSTSISAEGKTMR CCCCCCCCCCCCCCC | 21.75 | 22199227 | |
| 509 (in isoform 2) | Ubiquitination | - | 30.37 | 21890473 | |
| 509 | Ubiquitination | STSISAEGKTMRQPS CCCCCCCCCCCCCCH | 30.37 | 21963094 | |
| 510 (in isoform 1) | Ubiquitination | - | 30.56 | 21890473 | |
| 510 | Ubiquitination | TSISAEGKTMRQPSV CCCCCCCCCCCCCHH | 30.56 | 21906983 | |
| 511 | Phosphorylation | SISAEGKTMRQPSVI CCCCCCCCCCCCHHH | 28.57 | - | |
| 511 (in isoform 3) | Ubiquitination | - | 28.57 | 21890473 | |
| 530 | Ubiquitination | QNKREQIKNFLSKRV HCHHHHHHHHHHHHH | 41.14 | 29967540 | |
| 534 | Ubiquitination | EQIKNFLSKRVLIMY HHHHHHHHHHHHHHH | 17.80 | 24816145 | |
| 535 | Ubiquitination | QIKNFLSKRVLIMYF HHHHHHHHHHHHHHH | 48.99 | 24816145 | |
| 541 | Phosphorylation | SKRVLIMYFFSKHPE HHHHHHHHHHHCCHH | 8.42 | 23909892 | |
| 544 | Phosphorylation | VLIMYFFSKHPEASI HHHHHHHHCCHHHHH | 21.84 | 23909892 | |
| 588 | Ubiquitination | FGVVQTTLPAILNTL CCCHHHHHHHHHHHH | 2.83 | 21890473 | |
| 588 | Ubiquitination | FGVVQTTLPAILNTL CCCHHHHHHHHHHHH | 2.83 | 21890473 | |
| 619 | O-linked_Glycosylation | SSKPPRISGSLVDTS CCCCCCCCCCEECCC | 24.49 | 28411811 | |
| 621 | Phosphorylation | KPPRISGSLVDTSYK CCCCCCCCEECCCHH | 20.59 | 25247763 | |
| 624 | Ubiquitination | RISGSLVDTSYKTLR CCCCCEECCCHHHHH | 34.92 | 29967540 | |
| 625 | Phosphorylation | ISGSLVDTSYKTLRF CCCCEECCCHHHHHH | 26.86 | 21815630 | |
| 627 | Ubiquitination | GSLVDTSYKTLRFAF CCEECCCHHHHHHHH | 15.30 | 21890473 | |
| 627 (in isoform 2) | Ubiquitination | - | 15.30 | 21890473 | |
| 627 | Ubiquitination | GSLVDTSYKTLRFAF CCEECCCHHHHHHHH | 15.30 | 21890473 | |
| 628 (in isoform 1) | Ubiquitination | - | 40.63 | 21890473 | |
| 628 | Ubiquitination | SLVDTSYKTLRFAFR CEECCCHHHHHHHHH | 40.63 | 22817900 | |
| 633 | Ubiquitination | SYKTLRFAFRASLKT CHHHHHHHHHHHHHH | 6.13 | 21963094 | |
| 664 | Ubiquitination | QASAEHQKRLQQFLE HHHHHHHHHHHHHHH | 57.91 | 29967540 | |
| 672 | Ubiquitination | RLQQFLEFKE----- HHHHHHHHCC----- | 13.49 | 21963094 | |
| 673 | Ubiquitination | LQQFLEFKE------ HHHHHHHCC------ | 53.81 | 21963094 | |
| 673 | 2-Hydroxyisobutyrylation | LQQFLEFKE------ HHHHHHHCC------ | 53.81 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NDC1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NDC1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NDC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of NDC1_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406; THR-410; THR-414;SER-439; THR-440; SER-445; THR-449; SER-471 AND SER-474, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406; THR-414; SER-471AND SER-474, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406, AND MASSSPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406 AND THR-414, ANDMASS SPECTROMETRY. | |